Icon

LEVOTHYROXINE SODIUM (nda202231)- (100MCG/VIAL,200MCG/VIAL,500MCG/VIAL)

LEVOTHYROXINE SODIUM FRESENIUS KABI USA
100MCG/VIAL,200MCG/VIAL,500MCG/VIAL
Yes Yes
2032-Oct-03 Expired
None None
None No
Levothyroxine Sodium is an L-thyroxine product. Levothyroxine (T4) Sodium for Injection is indicated for the treatment of myxedema coma.
3 0 3
Total Other Developers None
Drugs with Suitability No
100MCG/VIAL ** ** - - -
200MCG/VIAL ** ** - - -
500MCG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******** ******* ************, *.*.*. *********** ***** ***** **., *****, **** (**) *****, ****** ****** (***) ***
****** **** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** ***. ***/*/* *** ***/*/*, ******** - ***** *******, ******* - *****, ****** - ********, ********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.